Our study reveals that T3 activates the tumor suppressor LKB1/AMPK/Raptor signaling axis, ultimately suppressing ENO2-mediated glycolysis and inhibiting HCC progression. The gene discussed is RPTOR; the disease is hepatocellular carcinoma.